Harbour Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Harbour Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80	Closed	-$8.73K	–	3156
2023 Q1	$8.73K	Sell	80 -51	-39%	-$5.64K	﹤0.01%	2073
2022 Q4	$14.9K	Sell	131 -521	-80%	-$43.3K	﹤0.01%	1791
2022 Q3	$52K	Hold	652	–	–	﹤0.01%	1253
2022 Q2	$52K	Buy	+652	New	+$61.7K	﹤0.01%	1253
2021 Q4	$55K	Sell	510 -261	-34%	-$28.5K	﹤0.01%	1228
2021 Q3	$84K	Buy	771 +11	+1%	+$1.14K	﹤0.01%	1485
2021 Q2	$71K	Sell	760 -97	-11%	-$8.93K	﹤0.01%	1598
2021 Q1	$79K	Buy	+857	New	+$72.3K	﹤0.01%	1426

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Harbour Investments's HZNP Position: Q2 2023 in Review

Harbour Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 80 shares — an estimated $8.73K sold.

Harbour Investments first reported a position in HZNP in Q1 2021 and held it in 8 quarters. The position peaked at $84K in Q3 2021. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Harbour Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Harbour Investments sold 80 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $8.73K.
Harbour Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 8 quarters.
Harbour Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $84K in Q3 2021.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Harbour Investments's 13F filing for Q2 2023, filed 15 Aug 2023.